IFN-alpha in the Generation of Dendritic Cells for Cancer Immunotherapy
- 1 January 2009
- book chapter
- Published by Springer Nature
- No. 188,p. 295-317
Abstract
Dendritic cells (DCs) play a crucial role in linking innate and adaptive immunity, by virtue of their unique ability to take up and process antigens in the peripheral blood and tissues and, upon migration to draining lymph nodes, to present antigen to resting lymphocytes. Notably, these DC functions are modulated by cy-tokines and chemokines controlling the activation and maturation of these cells, thus shaping the response towards either immunity or tolerance. An ensemble of recent studies have emphasized an important role of type I IFNs in the DC differentiation/activation, suggesting the existence of a natural alliance between these cytokines and DCs in linking innate and adaptive immunity. Herein, we will review how type I IFNs can promote the ex vivo differentiation of human DCs and orient DC functions towards the priming and expansion of protective antitumor immune responses. We will also discuss how the knowledge on type I IFN-DC interactions could be exploited for the design of more selective and effective strategies of cancer immunotherapy.Keywords
This publication has 79 references indexed in Scilit:
- Dendritic Cell Vaccination Induces Tumor Epitope-specific Th1 Immune Response in Medullary Thyroid CarcinomaHormone and Metabolic Research, 2008
- Molecular characteristics of immunogenic cancer cell deathCell Death & Differentiation, 2007
- Monocyte derived dendritic cells generated by IFN-α acquire mature dendritic and natural killer cell properties as shown by gene expression analysisJournal of Translational Medicine, 2007
- DC-based cancer vaccinesJournal of Clinical Investigation, 2007
- Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell PrecursorsCancer Research, 2006
- Immunogenic Cell Death and Cross-Priming Are Reaching the Clinical Immunotherapy ArenaClinical Cancer Research, 2006
- IL-6 Produced by Type I IFN DC Controls IFN-γ Production by Regulating the Suppressive Effect of CD4+ CD25+ Regulatory T CellsHuman Immunology, 2005
- IFN-α promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatmentBlood, 2004
- The disabled dendritic cellThe FASEB Journal, 2001
- Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α TreatmentActa Oncologica, 1991